Aravive Receives Additional $2.6 Million Disbursement from the Cancer Prevention and Research Institute of Texas
Aravive, Inc. (ARAV)
Last aravive, inc. earnings: 3/27 08:00 am
Check Earnings Report
Company Research
Source: GlobeNewswire
HOUSTON, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company, today announced that the company has received an additional $2.6 million disbursement from the Cancer Prevention and Research Institute of Texas (CPRIT). The grant continues to support Aravive’s operations and on-going clinical development of AVB-S6-500. In July 2016, CPRIT awarded Aravive $20 million for the development of AVB-S6-500. This $2.6 million brings the total disbursement to $18.0 million of the $20 million. Since the original grant, Aravive has advanced AVB-S6-500 from preclinical development, through a successful Phase 1a clinical trial in healthy volunteers and is now conducting the phase 1b portion of a phase 1b/2 clinical trial in patients with platinum-resistant recurrent ovarian cancer. The company also recently announced that it plans to initiate clinical trials of AVB-S6-500 in additional oncology indications as well as fibrotic indications. “Ara
Show less
Read more
Impact Snapshot
Event Time:
ARAV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARAV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARAV alerts
High impacting Aravive, Inc. news events
Weekly update
A roundup of the hottest topics